Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan K Rathe

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry|June 20, 2015
Synthesis and antileukemic activities of C1-C10-modified parthenolide analoguesAaron M Kempema, John C Widen, Joseph K Hexum, et al.
Scientific Reports|August 14, 2014
Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemiaSusan K Rathe, Branden S Moriarity, Christopher B Stoltenberg, et al.
Scientific Reports|December 15, 2016
Slit-Robo GTPase-Activating Protein 2 as a metastasis suppressor in osteosarcomaTracy A Marko, Ghaidan A Shamsan, Elizabeth N Edwards, et al.
Molecular Cancer Research : MCR|October 26, 2018
<i>Sleeping Beauty</i> Screen Identifies <i>RREB1</i> and Other Genetic Drivers in Human B-cell LymphomaEric P Rahrmann, Natalie K Wolf, George M Otto, et al.
Cancer Research|October 26, 2017
Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in OsteosarcomaMilcah C Scott, Nuri A Temiz, Anne E Sarver, et al.
Blood|October 16, 2014
NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemiaZohar Sachs, Rebecca S LaRue, Hanh T Nguyen, et al.
Bone|April 7, 2020
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcomaBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Differential migration mechanics and immune responses of glioblastoma subtypesGhaidan A Shamsan, Chao J Liu, Brooke C Braman, et al.
Molecular Cancer Therapeutics|October 1, 2020
Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic OsteosarcomaBranden A Smeester, Garrett M Draper, Nicholas J Slipek, et al.
Nature Genetics|May 12, 2015
A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasisBranden S Moriarity, George M Otto, Eric P Rahrmann, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Bioorganic & Medicinal Chemistry|June 20, 2015
Synthesis and antileukemic activities of C1-C10-modified parthenolide analoguesAaron M Kempema, John C Widen, Joseph K Hexum, et al.
Scientific Reports|August 14, 2014
Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemiaSusan K Rathe, Branden S Moriarity, Christopher B Stoltenberg, et al.
Scientific Reports|December 15, 2016
Slit-Robo GTPase-Activating Protein 2 as a metastasis suppressor in osteosarcomaTracy A Marko, Ghaidan A Shamsan, Elizabeth N Edwards, et al.
Molecular Cancer Research : MCR|October 26, 2018
<i>Sleeping Beauty</i> Screen Identifies <i>RREB1</i> and Other Genetic Drivers in Human B-cell LymphomaEric P Rahrmann, Natalie K Wolf, George M Otto, et al.
Cancer Research|October 26, 2017
Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in OsteosarcomaMilcah C Scott, Nuri A Temiz, Anne E Sarver, et al.
Blood|October 16, 2014
NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemiaZohar Sachs, Rebecca S LaRue, Hanh T Nguyen, et al.
Bone|April 7, 2020
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcomaBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2025
Differential migration mechanics and immune responses of glioblastoma subtypesGhaidan A Shamsan, Chao J Liu, Brooke C Braman, et al.
Molecular Cancer Therapeutics|October 1, 2020
Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic OsteosarcomaBranden A Smeester, Garrett M Draper, Nicholas J Slipek, et al.
Nature Genetics|May 12, 2015
A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasisBranden S Moriarity, George M Otto, Eric P Rahrmann, et al.
Pageof 2